Shares of Aurora Cannabis Inc. (TSE:ACB – Get Rating) reached a new 52-week low during trading on Friday after Stifel Nicolaus lowered their price target on the stock from C$2.15 to C$1.75. The stock traded as low as C$1.52 and last traded at C$1.57, with a volume of 1403886 shares changing hands. The stock had previously closed at C$1.66.
Other equities research analysts have also issued reports about the company. Cowen lifted their price target on Aurora Cannabis from C$1.85 to C$2.00 in a report on Tuesday, July 19th. Canaccord Genuity Group raised Aurora Cannabis from a “sell” rating to a “hold” rating and reduced their price objective for the stock from C$2.50 to C$2.00 in a research note on Wednesday. ATB Capital raised Aurora Cannabis from an “underperform” rating to a “sector perform” rating and increased their target price for the company from C$3.00 to C$4.00 in a research note on Thursday. Piper Sandler lowered their price target on Aurora Cannabis to C$4.00 and set a “neutral” rating for the company in a report on Wednesday. Finally, CIBC decreased their price objective on Aurora Cannabis from C$3.75 to C$2.50 and set a “neutral” rating for the company in a report on Monday. Ten investment analysts have rated the stock with a hold rating, According to MarketBeat, Aurora Cannabis presently has a consensus rating of “Hold” and a consensus price target of C$3.53.
Aurora Cannabis Stock Performance
The company has a debt-to-equity ratio of 35.61, a quick ratio of 3.95 and a current ratio of 5.85. The company has a market cap of C$476.44 million and a PE ratio of -0.27. The firm’s 50 day moving average is C$1.97 and its 200-day moving average is C$2.84.
Aurora Cannabis Company Profile
Aurora Cannabis Inc produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients.
- Why Does Tesla Stock Remain Resilient?
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
- Is Costco’s Post-Earnings Price Weakness A Good Time To Buy?
- 2 Semiconductor Stocks To Watch For Reversals
- Will Crowdstrike Get A Boost From Increased EPS Guidance?
Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.